Chemical Development, Bristol-Myers Squibb, One Squibb Drive, New Brunswick, NJ 08903, USA.
J Ind Microbiol Biotechnol. 2012 Dec;39(12):1789-99. doi: 10.1007/s10295-012-1189-7. Epub 2012 Aug 29.
Biotransformation of the highly substituted pyridine derivative 2-amino-4-methyl-3-nitropyridine by Cunninghamella elegans ATCC 26269 yielded three products each with a molecular weight of 169 Da which were identified as 2-amino-5-hydroxy-4-methyl-3-nitropyridine, 2-amino-4-hydroxymethyl-3-nitropyridine, and 2-amino-4-methyl-3-nitropyridine-1-oxide. Biotransformation by Streptomyces antibioticus ATCC 14890 gave two different products each with a molecular weight of 169 Da; one was acid labile and converted to the other stable product under acidic conditions. The structure of the stable product was established as 2-amino-4-methyl-3-nitro-6(1H)-pyridinone, and that of the less stable product was assigned as its tautomer 2-amino-6-hydroxy-4-methyl-3-nitropyridine. Four of the five biotransformation products are new compounds. Several strains of Aspergillus also converted the same substrate to the lactam 2-amino-4-methyl-3-nitro-6(1H)-pyridinone. Microbial hydroxylation by C. elegans was found to be inhibited by sulfate ion. In order to improve the yield and productivity of the 5-hydroxylation reaction by C. elegans, critical process parameters were determined and Design of Experiments (DOE) analyses were performed. Biotransformation by C. elegans was scaled up to 15-l fermentors providing 2-amino-5-hydroxy-4-methyl-3-nitropyridine at ca. 13 % yield in multi-gram levels. A simple isolation process not requiring chromatography was developed to provide purified 2-amino-5-hydroxy-4-methyl-3-nitropyridine of excellent quality.
被 Cunninghamella elegans ATCC 26269 生物转化的高度取代吡啶衍生物 2-氨基-4-甲基-3-硝基吡啶产生了三种分子量均为 169 Da 的产物,它们分别被鉴定为 2-氨基-5-羟基-4-甲基-3-硝基吡啶、2-氨基-4-羟甲基-3-硝基吡啶和 2-氨基-4-甲基-3-硝基吡啶-1-氧化物。Streptomyces antibioticus ATCC 14890 的生物转化生成了两种不同的分子量均为 169 Da 的产物;其中一种产物在酸性条件下不稳定,会转化为另一种稳定的产物。稳定产物的结构被确定为 2-氨基-4-甲基-3-硝基-6(1H)-吡啶酮,而不太稳定产物的结构被指定为其互变异构体 2-氨基-6-羟基-4-甲基-3-硝基吡啶。这五种生物转化产物中有四种是新化合物。几种曲霉属菌株也将相同的底物转化为内酰胺 2-氨基-4-甲基-3-硝基-6(1H)-吡啶酮。发现 C. elegans 的微生物羟化作用受到硫酸根离子的抑制。为了提高 C. elegans 5-羟化反应的产率和生产力,确定了关键工艺参数并进行了实验设计(DoE)分析。C. elegans 的生物转化扩大到 15 升发酵罐,在多克级水平上提供约 13%产率的 2-氨基-5-羟基-4-甲基-3-硝基吡啶。开发了一种不需要色谱的简单分离工艺,可提供优质的纯化 2-氨基-5-羟基-4-甲基-3-硝基吡啶。